Home › Funds › ArrowMark Colorado Holdings LLC › DFTX
ArrowMark Colorado Holdings LLC position in DFTX
DEFINIUM THERAPEUTICS INC · Health Care
ArrowMark Colorado Holdings LLC reported holding 564,069 shares of DFTX (DEFINIUM THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$26.5M, representing 1.10% of its reported portfolio and ranking #10 among its reported holdings. ArrowMark Colorado Holdings LLC has disclosed DFTX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ArrowMark Colorado Holdings LLC's DFTX position evolved
ArrowMark Colorado Holdings LLC first disclosed a stake in DFTX in Q1 2026 at 1,594,717 shares (US$30.1M). Across 2 filings, ArrowMark Colorado Holdings LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 564,069 shares valued at US$26.5M — a reduction of -1,030,648 shares quarter over quarter.. Notable position changes include a 65% trim in Q2 2026 (shares fell 19% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 1.59M | $30.14M | New |
| Q2 2026 | 564.07K | $26.53M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DFTX and 13F data
DFTX (DEFINIUM THERAPEUTICS INC) is a Health Care company. 189 other funds we track also report a position in DFTX — the largest reported positions include Avoro Capital Advisors LLC (US$338.2M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$322.0M), Octagon Capital Advisors LP (US$138.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DFTX
- Avoro Capital Advisors LLC 7.19M sh · $338.17M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 6.85M sh · $322.00M · Q2 2026
- Octagon Capital Advisors LP 2.95M sh · $138.77M · Q2 2026
- Deep Track Capital, LP 2.75M sh · $129.36M · Q2 2026
- Commodore Capital LP 2.00M sh · $94.08M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 1.50M sh · $70.56M · Q2 2026
- Siren, L.L.C. 1.42M sh · $66.77M · Q2 2026
- Boxer Capital Management, LLC 998.50K sh · $46.97M · Q2 2026
- AWM Investment Company, Inc. 784.80K sh · $36.92M · Q2 2026
- Catalio Capital Management, LP 562.67K sh · $26.47M · Q2 2026
- Integral Health Asset Management, LLC 550.00K sh · $25.87M · Q2 2026
- GREAT POINT PARTNERS LLC 425.00K sh · $19.99M · Q2 2026
More on ArrowMark Colorado Holdings LLC
FAQ
How long has ArrowMark Colorado Holdings LLC held DFTX?
ArrowMark Colorado Holdings LLC has disclosed DFTX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is ArrowMark Colorado Holdings LLC's current position in DFTX?
As of Q2 2026, ArrowMark Colorado Holdings LLC holds 564.07K shares of DFTX (DEFINIUM THERAPEUTICS INC), valued at $26.53M, representing 1.10% of its reported portfolio and ranking #10.
Has ArrowMark Colorado Holdings LLC been buying or selling DFTX?
In the latest 13F filing (Q2 2026), ArrowMark Colorado Holdings LLC reduced its position in DFTX.
Which other funds hold DFTX?
Other major institutional holders of DFTX include Avoro Capital Advisors LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, Octagon Capital Advisors LP, among 189 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.